Thomas Gabrielczyk's articles Biotechnology FoRx raises US$50m in Series A to advance PARG inhibitor FoRx Therapeutics AG has closed a US$50m (CHF40m) Series A financing, in addition to its 2020 seed financing of US$10m. The Basel-based company develops precision oncology therapeutics. Funds advance Phase I development of lead candidate FORX-428. The round was insider-led and strategically oversubscribed. Existing investors supported the financing. They include EQT Life Sciences, Pfizer Ventures […] Written by Thomas Gabrielczyk December 18, 2025December 18, 2025 Saving Bookmark this article Bookmarked Biotechnology Angelini Ventures and EIB launch joint start-up financing As part of the TechEU initiative, the EIB and Angelini will co-invest €150m in high-potential biotechnology, medical technology, and digital health start-ups. Announced today at a press conference at Angelini Ventures’ headquarters in Rome, the initiative forms part of TechEU, the EIB Group’s investment programme to strengthen Europe’s innovation ecosystem and technological leadership. Through TechEU, […] Written by Thomas Gabrielczyk December 1, 2025December 1, 2025 Saving Bookmark this article Bookmarked Biotechnology Avanzanite secures €32m Series A funding Avanzanite Bioscience NV has raised €32m in a Series A financing round from MVM Partners, marking the company’s first institutional investment since its founding in 2022. The funding will support the expansion of Avanzanite’s operational infrastructure across 32 European countries, accelerate the commercialisation of existing and upcoming orphan drugs, and enable the company to form new […] Written by Thomas Gabrielczyk November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked Biotechnology Novo and Pfizer in Metsera takeover battle In a surprising move, Novo Nordisk A/S has overbid Pfizer Inc.’s M&A tender for Metsera Inc by US$1.9bn. Metsera develops GLP-1 and amylin-based therapeutics. GLP-1 (glucagon-like peptide-1) increases insulin secretion. It suppresses glucagon production. This lowers blood sugar levels. Amylin slows gastric emptying. It increases the feeling of satiety. Long-acting formulation The lead candidate, MET-097i, […] Written by Thomas Gabrielczyk November 1, 2025November 1, 2025 Saving Bookmark this article Bookmarked Biotechnology MSD Secures Option on EVX-B3 Under the agreement, MSD will assume full responsibility and carry all costs for the further development of the EVX-B3 vaccine. The vaccine is designed to combat pathogens that cause opportunistic, recurrent infections, such as S. aureus, Enterococcus sp., and uropathogenic E. coli. So far, the companies have not disclosed further details, but the vaccine is reportedly […] Written by Thomas Gabrielczyk September 29, 2025September 29, 2025 Saving Bookmark this article Bookmarked Biotechnology Calluna Pharma starts efficacy test with unique IPF antibody Among the 110 drug development programmes currently underway worldwide targeting the US$4.5bn IPF market, Calluna Pharma‘s IgG1 antibody directed against the damage-associated molecular pattern (DAMP) protein S100A4 stands out for its unique mechanism of action. Preclinical studies demonstrated selective inhibition of both fibroblast activation and pro-fibrotic inflammation, alongside a favourable safety and immunogenicity profile, which […] Written by Thomas Gabrielczyk August 27, 2025August 27, 2025 Saving Bookmark this article Bookmarked Biotechnology Dewpoint Therapeutics cuts workforce, refocuses pipeline Despite securing US$287m from 16 investors across three funding rounds—US$60m (Series A, 2019), US$77m (Series B, 2020), and US$150m (Series C, 2022)—the firm cited a high burn rate as the reason for scaling back. Dewpoint will now prioritise clinical development of its lead candidate, DPTx3186, a beta-catenin inhibitor targeting the WNT signalling pathway, in gastric […] Written by Thomas Gabrielczyk August 10, 2025August 10, 2025 Saving Bookmark this article Bookmarked Biotechnology UK Food Standards Agency accepts Gourmey’s application for cultivated Foie Gras The acceptance by the UK marks a new phase in what is emerging as a closely observed regulatory race. With similar food safety requirements across the EU, the US, Singapore, Switzerland and the UK, the process will provide insights into which regulatory frameworks are most efficient in assessing and approving novel food technologies. Earlier this […] Written by Thomas Gabrielczyk July 11, 2025July 11, 2025 Saving Bookmark this article Bookmarked Biotechnology EU Commissioner Várhelyi revives Biotech Act for 2025 In a panel discussion at Medicines for Europe Annual Conference, EU Health Commissioner Olivér Várhelyi made a surprise announcement that the Commission will adopt the EU Biotech Act by the end of this year, citing growing “global challenges”. According to the EU Commission’s work programme, the legislation was initially scheduled for adoption in Q3 2025, […] Written by Thomas Gabrielczyk June 28, 2025June 28, 2025 Saving Bookmark this article Bookmarked Biotechnology GEA to open food biotech pilot-scale facility in USA Similar to GEA’s initial scaling facility for cell-based food production in Germany, the recently opened 10,000-square-metre facility in Janesville, Wisconsin is intended to assist scientists and entrepreneurs in the developing food technology sector to increase their production to industrial levels. With a 40% market share and a thriving start-up scene, the US is ahead of […] Written by Thomas Gabrielczyk June 14, 2025June 14, 2025 Saving Bookmark this article Bookmarked Biotechnology EU set to improve investment for biotech start-ups and scale-ups The European Commission has unveiled a new strategy entitled ‘Choose Europe to start and scale’, which aims to strengthen the development and financing of start-ups and scale-ups within the European Union, particularly in innovation-driven sectors such as biotechnology, quantum computing and deep tech. The strategy, published on 28 May 2025, addresses the challenges faced by […] Written by Thomas Gabrielczyk June 1, 2025June 1, 2025 Saving Bookmark this article Bookmarked Biotechnology Countdown to SLAS Europe: NestEgg Labs BV Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […] Written by Thomas Gabrielczyk May 19, 2025May 19, 2025 Saving Bookmark this article Bookmarked Loading Load more
Biotechnology FoRx raises US$50m in Series A to advance PARG inhibitor FoRx Therapeutics AG has closed a US$50m (CHF40m) Series A financing, in addition to its 2020 seed financing of US$10m. The Basel-based company develops precision oncology therapeutics. Funds advance Phase I development of lead candidate FORX-428. The round was insider-led and strategically oversubscribed. Existing investors supported the financing. They include EQT Life Sciences, Pfizer Ventures […] Written by Thomas Gabrielczyk December 18, 2025December 18, 2025 Saving Bookmark this article Bookmarked
Biotechnology Angelini Ventures and EIB launch joint start-up financing As part of the TechEU initiative, the EIB and Angelini will co-invest €150m in high-potential biotechnology, medical technology, and digital health start-ups. Announced today at a press conference at Angelini Ventures’ headquarters in Rome, the initiative forms part of TechEU, the EIB Group’s investment programme to strengthen Europe’s innovation ecosystem and technological leadership. Through TechEU, […] Written by Thomas Gabrielczyk December 1, 2025December 1, 2025 Saving Bookmark this article Bookmarked
Biotechnology Avanzanite secures €32m Series A funding Avanzanite Bioscience NV has raised €32m in a Series A financing round from MVM Partners, marking the company’s first institutional investment since its founding in 2022. The funding will support the expansion of Avanzanite’s operational infrastructure across 32 European countries, accelerate the commercialisation of existing and upcoming orphan drugs, and enable the company to form new […] Written by Thomas Gabrielczyk November 18, 2025November 18, 2025 Saving Bookmark this article Bookmarked
Biotechnology Novo and Pfizer in Metsera takeover battle In a surprising move, Novo Nordisk A/S has overbid Pfizer Inc.’s M&A tender for Metsera Inc by US$1.9bn. Metsera develops GLP-1 and amylin-based therapeutics. GLP-1 (glucagon-like peptide-1) increases insulin secretion. It suppresses glucagon production. This lowers blood sugar levels. Amylin slows gastric emptying. It increases the feeling of satiety. Long-acting formulation The lead candidate, MET-097i, […] Written by Thomas Gabrielczyk November 1, 2025November 1, 2025 Saving Bookmark this article Bookmarked
Biotechnology MSD Secures Option on EVX-B3 Under the agreement, MSD will assume full responsibility and carry all costs for the further development of the EVX-B3 vaccine. The vaccine is designed to combat pathogens that cause opportunistic, recurrent infections, such as S. aureus, Enterococcus sp., and uropathogenic E. coli. So far, the companies have not disclosed further details, but the vaccine is reportedly […] Written by Thomas Gabrielczyk September 29, 2025September 29, 2025 Saving Bookmark this article Bookmarked
Biotechnology Calluna Pharma starts efficacy test with unique IPF antibody Among the 110 drug development programmes currently underway worldwide targeting the US$4.5bn IPF market, Calluna Pharma‘s IgG1 antibody directed against the damage-associated molecular pattern (DAMP) protein S100A4 stands out for its unique mechanism of action. Preclinical studies demonstrated selective inhibition of both fibroblast activation and pro-fibrotic inflammation, alongside a favourable safety and immunogenicity profile, which […] Written by Thomas Gabrielczyk August 27, 2025August 27, 2025 Saving Bookmark this article Bookmarked
Biotechnology Dewpoint Therapeutics cuts workforce, refocuses pipeline Despite securing US$287m from 16 investors across three funding rounds—US$60m (Series A, 2019), US$77m (Series B, 2020), and US$150m (Series C, 2022)—the firm cited a high burn rate as the reason for scaling back. Dewpoint will now prioritise clinical development of its lead candidate, DPTx3186, a beta-catenin inhibitor targeting the WNT signalling pathway, in gastric […] Written by Thomas Gabrielczyk August 10, 2025August 10, 2025 Saving Bookmark this article Bookmarked
Biotechnology UK Food Standards Agency accepts Gourmey’s application for cultivated Foie Gras The acceptance by the UK marks a new phase in what is emerging as a closely observed regulatory race. With similar food safety requirements across the EU, the US, Singapore, Switzerland and the UK, the process will provide insights into which regulatory frameworks are most efficient in assessing and approving novel food technologies. Earlier this […] Written by Thomas Gabrielczyk July 11, 2025July 11, 2025 Saving Bookmark this article Bookmarked
Biotechnology EU Commissioner Várhelyi revives Biotech Act for 2025 In a panel discussion at Medicines for Europe Annual Conference, EU Health Commissioner Olivér Várhelyi made a surprise announcement that the Commission will adopt the EU Biotech Act by the end of this year, citing growing “global challenges”. According to the EU Commission’s work programme, the legislation was initially scheduled for adoption in Q3 2025, […] Written by Thomas Gabrielczyk June 28, 2025June 28, 2025 Saving Bookmark this article Bookmarked
Biotechnology GEA to open food biotech pilot-scale facility in USA Similar to GEA’s initial scaling facility for cell-based food production in Germany, the recently opened 10,000-square-metre facility in Janesville, Wisconsin is intended to assist scientists and entrepreneurs in the developing food technology sector to increase their production to industrial levels. With a 40% market share and a thriving start-up scene, the US is ahead of […] Written by Thomas Gabrielczyk June 14, 2025June 14, 2025 Saving Bookmark this article Bookmarked
Biotechnology EU set to improve investment for biotech start-ups and scale-ups The European Commission has unveiled a new strategy entitled ‘Choose Europe to start and scale’, which aims to strengthen the development and financing of start-ups and scale-ups within the European Union, particularly in innovation-driven sectors such as biotechnology, quantum computing and deep tech. The strategy, published on 28 May 2025, addresses the challenges faced by […] Written by Thomas Gabrielczyk June 1, 2025June 1, 2025 Saving Bookmark this article Bookmarked
Biotechnology Countdown to SLAS Europe: NestEgg Labs BV Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […] Written by Thomas Gabrielczyk May 19, 2025May 19, 2025 Saving Bookmark this article Bookmarked
